# PediaRounds cross-chat coordination state

Updated: 2026-09-07
Branch: `master-bank/review-images-verification`
PR: **#5 — Review images, incomplete recalls, and clinical verification**
Base: `main`

## Structural baseline
- 1023 records scanned.
- 1022/1022 enumerated source slots covered; 0 missing.
- Genetics TOC anomaly remains: TOC says 53, actual sequence ends at Q52. Do not fabricate Q53.
- Exact duplicate IDs: 0; section/Q collisions: 0.

## Completed quality milestones
- Sparse recalls: **167/167** directly re-read from source; no missing distractors/calculations invented.
- Sparse media cues: **48/48** technically reconciled.
- Outdated queue: **9/9** received current clinical review; recalled keys preserved.
- Conflicting queue assignment: **131/131 assigned; 0 unassigned.**

## Clinical conflict resolution — active
Resolution files:
- `review-queue/conflicting-clinical-resolution-batch01-12-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch02-8-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch02-heme-05-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch03-nephro-06-20260907.json`
- `review-queue/conflicting-clinical-resolution-batch04-endo-rheum-02-20260907.json`

### Aggregate clinical-resolution progress
- **33 conflicting records reviewed in current-guidance resolution passes.**
- **8 resolved to clean modern verified answers in review overlays.**
- **25 retained as invalid, under-specified, missing the best option, image-dependent, or context-dependent.**
- **0 recalledAnswer values overwritten.**

### Newly completed Endocrinology/Rheumatology pass — 2 reviewed
- Endocrinology Q15: **resolved to A, GnRH agonist should not be assumed to treat the gonadotropin-independent McCune-Albright precocious-puberty process.** Current MAS guidance uses aromatase/sex-steroid directed therapy for the peripheral process and adds GnRH agonist if secondary central puberty develops.
- Rheumatology Q12: **resolved to C, 8,000 WBC with 30% PMN**, as the best retained JIA synovial-fluid pattern. This is a best-fit choice, not a diagnostic cutoff; JIA usually has inflammatory fluid below the very high neutrophilic counts typical of acute bacterial arthritis.

## Important retained gates
- Ethics Q10/Q11: current Saudi/MOH DNR policy and perioperative DNR handling required.
- Research Q7/Q9: variable coding/diagnostic-table context missing; no answer should be forced.
- Trauma Q10: modern low-risk action is absent from retained options.
- Dermatology Q12: route depends on severity; source key/explanation conflict remains.
- Gastro Q35: congenital diarrhea differential unresolved without stool electrolytes.
- Gastro Q56/Q57: original imaging/definitive-study interpretation uncertain.
- Neonatology Q36: key and explanation disagree on brachial plexus root level.
- Infectious Q116: answer depends on Saudi vaccine-schedule version.
- Nephrology Q46: image missing and source answer unresolved.

## Shared execution rules
- GitHub is the shared memory across chats.
- Do not restart completed numbered, sparse, media, outdated, conflict-assignment, or already committed clinical-resolution work.
- Preserve `recalledAnswer` separately from `verifiedAnswer`.
- Do not invent missing options, calculations, media, years, stems, or keys.
- Original source images only; no generated substitutes for source-dependent MCQs.
- Source PDFs, credentials, and secrets must not be committed.

## Next shared batch
Continue large clinical-resolution passes through remaining Hematology, Endocrinology, Critical Care, Gastroenterology, and Infectious conflicts, then move to the `needs_verification` queue. Favor complete stems/options with a defensible modern single-best answer; otherwise keep non-publishable and document why.

## Coordination rule
If another chat advances PR #5, refetch this file and `MASTER_BANK_PROGRESS.md` before writing and follow the newest GitHub state.
